SBC SBC Medical Group Holdings Inc.

Price (delayed)

$5.09

Market cap

$523.49M

P/E Ratio

10.83

Dividend/share

N/A

EPS

$0.47

Enterprise value

$387.41M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 96

SBC Medical Group Holdings, Inc. provides management services to cosmetic treatment centers through a franchise model operating across Japan, Southeast Asia, and the United States. The Company operates a diversified ...

Highlights
The company's net income rose by 47% YoY and by 20% QoQ
The EPS has grown by 47% YoY and by 21% from the previous quarter
The company's gross profit fell by 13% YoY but it rose by 5% QoQ
The company's revenue fell by 7% YoY but it rose by 3.4% QoQ
The P/E is 19% above the last 4 quarters average of 9.1
SBC Medical Group Holdings's quick ratio has decreased by 15% YoY and by 12% from the previous quarter

Key stats

What are the main financial stats of SBC

SBC stock price

How has the SBC Medical Group Holdings stock price performed over time
Intraday
0.39%
1 week
3.88%
1 month
20.33%
1 year
20.33%
YTD
18.1%
QTD
3.04%

Financial performance

How have SBC Medical Group Holdings's revenue and profit performed over time
Revenue
$175.17M
Gross profit
$125.86M
Operating income
$65.41M
Net income
$49.03M
Gross margin
71.9%
Net margin
28%
SBC Medical Group Holdings's net margin has soared by 58% YoY and by 16% from the previous quarter
The company's net income rose by 47% YoY and by 20% QoQ
SBC Medical Group Holdings's operating margin has increased by 22% YoY and by 3.6% QoQ
The operating income has grown by 14% YoY and by 7% from the previous quarter

Price vs fundamentals

How does SBC's price correlate with its fundamentals

Growth

What is SBC Medical Group Holdings's growth rate over time

Valuation

What is SBC Medical Group Holdings stock price valuation
P/E
10.83
P/B
1.98
P/S
2.98
EV/EBIT
5.19
EV/EBITDA
4.65
EV/Sales
2.21
The EPS has grown by 47% YoY and by 21% from the previous quarter
The P/E is 19% above the last 4 quarters average of 9.1
SBC's price to book (P/B) is 24% more than its last 4 quarters average of 1.6
The company's equity rose by 8% YoY and by 3.3% QoQ
The P/S is 30% above the last 4 quarters average of 2.3
The company's revenue fell by 7% YoY but it rose by 3.4% QoQ

Efficiency

How efficient is SBC Medical Group Holdings business performance
SBC's return on equity is up by 26% year-on-year and by 18% since the previous quarter
The ROS has grown by 25% YoY and by 3.6% from the previous quarter
SBC's ROIC is down by 18% YoY but it is up by 3.4% from the previous quarter
The return on assets has increased by 14% year-on-year and by 13% since the previous quarter

Dividends

What is SBC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SBC.

Financial health

How did SBC Medical Group Holdings financials performed over time
SBC Medical Group Holdings's total liabilities has surged by 79% YoY and by 8% QoQ
The total assets has increased by 29% year-on-year and by 4.8% since the previous quarter
SBC Medical Group Holdings's debt is 82% less than its equity
The debt to equity has soared by 200% YoY but it has contracted by 10% from the previous quarter
The company's equity rose by 8% YoY and by 3.3% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.